Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FNJQG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,988
Award facts
- Contract value 100% obligated
- $7,987.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $7,987.62 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pen injectables. The contract, issued on July 24, 2025, with an ultimate completion date of July 25, 2025, was competitively awarded without set-aside designations. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location. This delivery order represents a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen's primary IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a diverse range of pharmaceutical products and medical supplies to military healthcare programs worldwide. Dupixent, a biologic immunosuppressant medication, is commonly prescribed for conditions including moderate-to-severe eczema, asthma, and chronic rhinosinusitis with nasal polyps, making it a critical therapeutic asset for Defense Health Agency beneficiaries and military personnel. Through its extensive federal contract portfolio with the Defense Logistics Agency, AmerisourceBergen has demonstrated consistent capability to meet competitive procurement requirements across diverse pharmaceutical categories, ranging from specialty biologics to generic medications and medical supplies.
Quick answers
Who was awarded contract SPE2DB25FNJQG?
SPE2DB25FNJQG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 24, 2025.
How much is contract SPE2DB25FNJQG worth?
The government has obligated $7,988 on SPE2DB25FNJQG.
Is contract SPE2DB25FNJQG an order under another contract?
Yes. SPE2DB25FNJQG is a delivery order under SPE2DB20D1004, an indefinite delivery contract.
Was contract SPE2DB25FNJQG competed?
The extent of competition for SPE2DB25FNJQG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award